Charles Cherington

Equibles does not estimate personal net worth.

About Charles Cherington

Charles Cherington was last confirmed as Chairman at Ernexa Therapeutics Inc. (ERNA) in a filing dated May 5, 2023. Earlier roles on record: Board Member at Ernexa Therapeutics Inc. (ERNA) until July 6, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed July 11, 2023 that Charles Cherington resigned as the Board, effective July 6, 2023.

“On July 6, 2023 Nicholas Singer and Charles Cherington resigned from the Board of Directors (the "Board") of Eterna Therapeutics Inc., a Delaware corporation (the "Company").”

Ernexa Therapeutics Inc. Form 8-K, filed July 11, 2023 · Read the filing

Affiliation history

Ernexa Therapeutics Inc. (ERNA)
Board Member

SEC 8-K

2021-03-25–2023-07-06
Ernexa Therapeutics Inc. (ERNA)
Chairman

Proxy statement

Start not stated–2023-05-05

Last confirmed by a filing; no departure on record

Company network

Ernexa Therapeutics Inc.

ERNA

Biotechnology · Healthcare

Chairman, Board Member

2021-03-25–2023-07-06

Recent activity

Executive change Resigned: the Board Ernexa Therapeutics Inc. (ERNA)
2023-07-06